a7f8805a6a8c30ca0415eb3701e83bae

BD MAX STAPHSR

BECTON DICKINSON DE COLOMBIA LTDA·II·Colombia INVIMA·Expires April 15, 2034

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: a7f8805a6a8c30ca0415eb3701e83bae
Expire date: April 15, 2034

Authorized company / Fabricante

Name (Spanish): BECTON DICKINSON DE COLOMBIA LTDA
Name (English): BECTON DICKINSON DE COLOMBIA LTDA

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS _x000D_ RELACIONADOS CON MUESTRAS PROCEDENTES DEL _x000D_ ORGANISMO HUMANO.

English

DETERMINATION OF THE DIFFERENT ANALYTES _x000D_ RELATED TO SAMPLES FROM THE _x000D_ HUMAN ORGANISM.

About this record

Access comprehensive regulatory information for BD MAX STAPHSR (BD MAX STAPHSR) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID a7f8805a6a8c30ca0415eb3701e83bae and manufactured by BECTON DICKINSON DE COLOMBIA LTDA. The device was registered on April 15, 2034.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.